Navigation Links
A New Drug for Halting Metastatic Kidney Cancer

A recent research reports the efficacy of a pharmaceutical drug named Sunitinib in halting the progress of metastatic kidney cancer. A comparative study of interferon and// sunitinib treatments found that sunitinib is more efficient in halting the progress of metastatic kidney cancer.

The work was published recently in the prestigious international medical journal, The New England Journal of Medicine and involved medical co-researchers from the Oncology Department of the University Hospital of Navarra, in collaboration with the Clinical Trials Area of the same Department.

To date the usual treatment for kidney cancer of a metastatic nature has been based solely on immunotherapy. In phase III of the research sunitinib was compared with interferon (a type of immunotherapy) in 750 patients with metastatic kidney cancer and it was shown that sunitinib is more efficient in halting the progress of the disease. 101 medical centres from all over the world took part in the research.

Given the short period of follow-up in the research, the effect of the treatment on survival rates could not be corroborated. Although, in general, the treatment is well tolerated, certain side effects can occur and have to be taken into consideration - hypothyroidism, high blood pressure and fatigue.

Metastatic kidney cancer is one of the cancer pathologies the treatment of which has made least progress in recent years. The usual treatment with immunotherapy had not shown clearly positive results in many patients. Sunitinib is one of the few pharmaceutical drugs that provide clear improvements in this type of cancer.

The mechanism of functioning of sunitinib is in blocking the generation of new blood vessels. Tumors, in order to grow, need to develop blood vessels and this pharmaceutical drug impedes their growth, blocking a factor known as VEGF, and other similar ones, which stimulate vascular growth. The use of sunitinib in Spain is t
'"/>




Page: 1 2

Related medicine news :

1. Anti-Retrovirals Capable of Halting Mental Illness in HIV Patients
2. Cholesterol-lowering Drug Effective at Halting Early Atherosclerosis
3. IMP3 the Novel Biomarker for Metastatic Cancer
4. Researchers Find Stem-cell Therapy Effective in Targeting Metastatic Cancer
5. Is Diabetes the Leading Cause of Kidney Failure in India
6. Kidney Stones - Interesting New Research implicates bacteria as its cause
7. Moderate Use of Analgesics - Not Associated With Kidney Dysfunction
8. New Dietary Approach To Manage Kidney Stones
9. Kidney cancer on the rise
10. Kidney function can be affected by lead exposure
11. Kidney Failure after Non-Kidney Transplants
Post Your Comments:
(Date:12/2/2008)...wire-FirstCall/ -- VirtualScopics, Inc.,(Nasdaq: ...ng for clinical,trials, today announced that its ... $14.7 million at the same time a year ago, a grea...klog as the amount remaining to be,recognized fro...e studies,included within the backlog ranges from...
(Date:12/2/2008)...nds Many Cite Prevention, Shedding, or Sharing Cos...e-USNewswire/ -- A New Center for State and Local ...re balancing retiree health care plans and their n...are in the American States examines how state adm...lth care benefits to central human resources (HR) ...
(Date:12/2/2008)...treated with radiation prior to surgery for advanc...currence and better overall survival rates, accord...xamined a treatment called neoadjuvant therapy, wh...pread of cancer, before surgery to remove the tumo...d/or radiation. , Neoadjuvant therapy should no...
(Date:12/2/2008)... from the Institute of Medicine proposes revisions... decrease the chances of fatigue-related medical e...these doctors in training. The report does not re...m the maximum average of 80 per week set by the Ac... (ACGME) in 2003, but rather reduces the maximum n...
Breaking Medicine News(10 mins):Health News:VirtualScopics Backlog Rises to a Record $27 Million 2Health News:VirtualScopics Backlog Rises to a Record $27 Million 3Health News:States View Limits on Retiree Health Benefits 2Health News:Revised hours and workloads for medical residents needed to prevent 2Health News:Revised hours and workloads for medical residents needed to prevent 3
...sday approved Wyeth's oral contraceptive Lybrel, w...riods, the Los Angeles Times reports. Lybrel, whi...a daily dose than traditional oral contraceptives,...The usual regimen for oral contraceptives is 21 ac...
...tter working conditions for nurses are safer for e...ng to a recent report , led by researchers that m...ospital associated infections are the number six c...7). Nurses, as the largest workforce in the nation...
...that obese patients with asthma are more likely to... not overweight . The study was conducted by a te... Holguin and colleagues at Emory University. As p...rchers conducted a survey of more than 3,000 adult...
... who smoke during pregnancy may be exposing their ...ivity disorder (ADHD), according to a study publis...y states that prenatal exposure to smoking in the ...ically susceptible children at an increased risk t...
Other Medicine News:Health News:FDA Approves Wyeth's Oral Contraceptive Lybrel 2Health News:Better Working Conditions for Nurses Might Decrease Patient Infections 2Health News:Better Working Conditions for Nurses Might Decrease Patient Infections 3Health News:Obesity Might Lead to Severe Persistent Asthma Attacks: Study 2
(Date:11/26/2008)...26 Children whose eyes ...tly increased risk of developing mental illness by... Clinic study published this month in Pediatrics ,...ediatrics. , , The retrospective study exam...bismus (misaligned eyes) and compared them with re...
(Date:11/25/2008)...5 Kleinert Kutz and Un...e fifth U.S. hand transplant on Messina, New York ...ish Hospital Hand Care Center on Monday, November ...d was completed shortly after 9 p.m. in a record n....com/cgi-bin/prnh/20081125/DC48555-a ) , (Photo...
(Date:11/25/2008)... 25 Pharmacyclics, Inc.,...y has completed a Phase 1,clinical trial with PCI...-molecule Factor VIIa inhibitor. The trial was con...uate the safety and pharmacologic effect of,PCI-2...d in a linear dose,response in the International ...
(Date:11/24/2008)...24 Domino,s Pizza (NYSE: DPZ ), ... gearing up to raise dough for,the kids of St. Ju...nnual,Thanks and Giving campaign. Domino,s custom...at point of purchase to benefit the children of St...the phone or when ordering online at, www.dominos...
Breaking Medicine Technology:Eye Divergence in Children Triples Risk of Mental Illness 2Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 2Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 3Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 2Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 3Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 4Domino's Pizza Pledges Support to the Fifth Annual St. Jude Children's Research Hospital(R) Thanks and Giving(R) Campaign 2Domino's Pizza Pledges Support to the Fifth Annual St. Jude Children's Research Hospital(R) Thanks and Giving(R) Campaign 3Study fuels debate over whether exercise and body size influence ovarian cancer risk 2180 1Study fuels debate over whether exercise and body size influence ovarian cancer risk 2180 2Study fuels debate over whether exercise and body size influence ovarian cancer risk 2180 3Susan G Komen for the Cure Partners With the Original Butter Bell 28R 29 Crock Developer 2176 1Susan G Komen for the Cure Partners With the Original Butter Bell 28R 29 Crock Developer 2176 2New Report Says a Pandemic is Overdue But Companies and Nations are ill Prepared to Cope With the Impact 2173 1New Report Says a Pandemic is Overdue But Companies and Nations are ill Prepared to Cope With the Impact 2173 2New Report Says a Pandemic is Overdue But Companies and Nations are ill Prepared to Cope With the Impact 2173 3New Report Says a Pandemic is Overdue But Companies and Nations are ill Prepared to Cope With the Impact 2173 4New Report Says a Pandemic is Overdue But Companies and Nations are ill Prepared to Cope With the Impact 2173 5Kensey Nash Reports Acceleration of Stock Awards Triggered by Shareholder Acquisition of Greater Than 20 25 of Outstanding Shares 2170 1Kensey Nash Reports Acceleration of Stock Awards Triggered by Shareholder Acquisition of Greater Than 20 25 of Outstanding Shares 2170 2Kensey Nash Reports Acceleration of Stock Awards Triggered by Shareholder Acquisition of Greater Than 20 25 of Outstanding Shares 2170 3Kensey Nash Reports Acceleration of Stock Awards Triggered by Shareholder Acquisition of Greater Than 20 25 of Outstanding Shares 2170 4
...s.--(BUSINESS WIRE)--Apr 12, 2007 - CombinatoRx,I...osters related,to its oncology research efforts wi...American Association for Cancer Research,April 14...ng of Targeted Chemical Combinations for,Cancer Th...resented,on Sunday, April 15, 1-5pm PT and "Synerg...
...ion pyridopyrazine-urea derivative compound series... be valuable for,cancer treatment, QUEBEC, April 1...Inc. , a global, pure play biopharmaceutical compa...y presented an abstract,outlining first in vitro d...lectivity for PI3K inhibition, at the American,Ass...
Other Medicine Technology:CombinatoRx to Present Combination High Throughput Screening (cHTS),Data at Upcoming AACR Meeting 2CombinatoRx to Present Combination High Throughput Screening (cHTS),Data at Upcoming AACR Meeting 3AEterna Zentaris Discloses First In Vitro Data for its PI3K,Inhibitors at the AACR Annual Meeting in Los Angeles 2AEterna Zentaris Discloses First In Vitro Data for its PI3K,Inhibitors at the AACR Annual Meeting in Los Angeles 3
These precision 4mL PYREX volumetric pipets are manufactured and calibrated "To Contain" (TC - bottom line) and "To Deliver" (TD - top line) to specifications for Class A volumetric ware. Pipets are
The new Finnpipette Focus from Thermo Labsystems was designed specifically to combine ergonomics with uncompromising performance. The new interchangeable handle plate offers a custom fit for differe
Inquire
A fixed pipette is ideal for repeated pipetting of a single volume. Fixed volume FInnpipettes offer the same features and advantages as other Finnpipette Digital pipettes: New, streamlined design, S
Medicine Products: